CSI Market
Sign In | Register

Surmodics Inc (SRDX) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access SRDX quarterly Cash Flow →
The quarterly cash flow data below helps track how Surmodics Inc's liquidity profile has evolved over recent quarters.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Sep 30 2024)
12 Months 		(Sep 30 2023) (Sep 30 2022) (Sep 30 2021) (Sep 30 2020)
Operating Activities
Income-11.54
Depreciation & amortization8.69
Amortization of Other Assets0.30
Increase (Decrease) in Deferred Revenue0.00
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability0.00
Provision For Loan Losses Expensed0.06
Increase (Decrease) in Inventories-0.33
Research and Development in Process0.00
Gain (Loss) on Disposition of Property Plant Equipment0.00
Share-based Compensation8.22
Income (Loss) from Equity Method Investments0.00
Foreign Currency Transaction Gain (Loss), Unrealized0.00
Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax-
Payment For Contingent Consideration Liability Operating Activities-
Increase Decrease In Accounts Receivable And Contract With Customer Asset-5.24
Noncash Lease Expense-
Operating Lease Right Of Use Asset Amortization Expense0.80
Increase Decrease In Contract With Customer Liability-5.16
Income taxes1.26
Gain (Loss) on Sale of Investments0.00
Increase (Decrease) in Accounts Receivable0.00
Increase (Decrease) in Accounts Payable-0.23
Increase (Decrease) in Accrued Liabilities-0.89
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets4.90
Other Working Capital0.00
Other Noncash Income (Expense)-0.61
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.00
Discontinued operations0.00
Net Cash flow from Operating Activities0.25
Investing Activities
Capital Expenditures-3.49
Sale of Capital Items0.00
Proceeds from Maturities, Prepayments and Calls of Available-for-sale Securities26.00
Payments to Acquire Available-for-sale Securities, Debt-25.45
Real Estate Investments0.00
Cash Received From Transferred To Discontinued Operations-
Cash Received Paid From Transferred To Discontinued Operations-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Proceeds from Sale of Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-2.94
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock1.22
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-44.65
Purchase Of Common Stock To Pay Employee Taxes-
Payment Of Contingent Consideration-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations41.42
Payments For Acquisition Of In Process Research And Development-0.93
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-2.95
Effect of exchange rate on cash flow0.34
Discontinued operations0.00
Free Cash Flow-3.24
Total Cash Flow-5.30
4 historic quarters locked

Sign in to unlock the full Surmodics Inc cash flow history.

Sign In Create Free Account

About Surmodics Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

  • Form: 10-K (Period: 20240930)
  • Filed with the SEC: November 20, 2024
  • Source: srdx-20240930.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0000950170-24-129020

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License